On Thursday, a panel of the Fed. Cir. affirmed a board decision refusing a patent claim to an animal prepared by adult cell cloning (a copy is available at the end of this post). Specifically, the patent claims covering “Dolly” the cloned sheep were held invalid on the basis that Dolly is a “product of [...]
The post Section 101 Fells Dolly: What Organism Is Next? appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.